Icon
+91 94997 68112
Login Register

Ambien CR - (6.25 mg, 12.5 mg; Tablet Extended Release)

Zolpidem Tartrate Sanofi
6.25 mg, 12.5 mg; Tablet Extended Release
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
 None
More Than 5
More Than 5
Indicated for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance (as measured by wake time after sleep onset).
Yes
***** ********* ******, *******, ****, ******, ****** (*** **** ** *******), ******, *** ***** ***** * **** ** ** ****** **. ** *****, ****** ***** ***-*** *********** *** (**.***) *** ******* *** (*.****). ****** *********, -, *******, ****, ****** (********** *** *********) *** ******, ******* ***** ******, *** ****** ***********. * ** *** ***** ** ****** ** *** ******** **** ******* ********, ***** **** ************ *** *********; **** ** *** ****** ******** *** ****** ******. ***** ******* ** **** **, ******* (*** *.****) *** ****** *** (**.***) *** *** ******** *** ******** *** ******* *******. *** ** *** ******* ********* *** **** ********* *** ** ******** ***** **** (******* ** ********** ****** ***********). ** ***** *** *** ********* ** *** *** **** ******* ***** *** *** ********* *** ****. ** **** **** ** ****** ***** ***-**** *********** ******** ***** **** ** **** ** ****** *** ******* ***** *** *********** ** ******** * *******.
Ambien CR Patent 1
****** *******
******* ****** *******
**** (****) *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
****** *** \ ** ****, **** ******* **** ****** **** ********
******* ****** ** \ ** ***, **** ******* **** ****** **** ********
**** (****) ** \ ** ***, **** ******* **** ****** **** ********
  1. ***, **** : ******, ****** *** ***** ***** **** ** ** ****** **, ******* ***** ********* **** *** *********, ** ***** ********* ******* ***** *** *** **** *********** *** *.**** ******** ******* ****** & ****** ***** *** ***** *** *** **** *********** *** **.*** ******.
  2. ***, **** : ****** ***** * **** ******* ****** ** ******** ***** ** ** ** ****** ******** ****** ***** *** ****** ****** **** ****** ** *** ****** '***.
  3. ***, **** : ****** ***** * **** ******* ******* ** ******** ***** ** ***** ******** ** ******* ******** ****** ***** *** ****** ****** **** ****** ** *** ****** '***.
  4. *****, **** : ****** ***** * **** ******* **** ** ******** ***** ** ** ** **** ******** ****** ***** *** ****** ****** **** ****** ** *** ****** '***.
  5. ***, **** : ****** ***** * **** ******* ****** ****** ** ******** ***** ** ***** ******** ** ****** ******** ****** ***** *** ****** ****** **** ****** ** *** ****** '*** **** ** *** **** **** ****** ***** * **(*** ***** *********** ******).
  6. *** **, **** : ********** ********* **** ****** ******
  7. *****, **** : ****** ***** * **** ******* ****** ** ******** ***** ** ***** ******** ** ****** ******** ****** ***** *** ****** ****** **** ****** ** *** ****** '***. ***** **** ***** ********* ******, ****** *** ***** **** **** ********* ****** ***** **** ** ** ****** **, ******* ***** ********* **** *** *********, ** **** ****** ***** ***.
  8. *** *, **** : ********** ********* **** ******
  9. ***, **** : ******'* ** *** ****** ******** *** ****** ******.
  10. *** **** : ******* ******** ******** & ******** *** *******.
  11. ***, **** : ****** ******** ******** *** ******** *** *******.
  12. *** *, **** : ********** ********* **** ****(****) *** ******
  13. *** *, **** : ********** ********* **** ******* ******

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.